Innocan Pharma Corp. buy EarningsForward40
Start price
22.01.25
/
50%
€0.11
Target price
22.02.25
-
Performance (%)
36.28%
End price
23.02.25
€0.15
Summary
This prediction ended on 23.02.25 with a price of €0.15. With a performance of 36.28% the BUY prediction by EarningsForward40 was a big success. EarningsForward40 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Innocan Pharma Corp. | - | - | - |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by EarningsForward40 for this prediction
In the thread Trading Innocan Pharma Corp.
Die von EarningsForward40 gewählte maximale Laufzeit wurde überschritten

